This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Harvard-Trained Cosmetic Surgeon And Former President Of The American Academy Of Cosmetic Surgery, Steven B. Hopping, M.D., F.A.C.S., Appointed As Senior Medical Advisor Of X-Change Corporation

DALLAS, Feb. 11, 2013 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is hemp extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, is proud to announce the appointment of internationally renowned cosmetic surgeon Steven B. Hopping, M.D., F.A.C.S. as Senior Medical Advisor, adding significant expertise to X-Change Corporation's team in skincare and other skin product indications, treatment, development, and sales. 

Dr. Hopping, a Harvard-trained cosmetic surgeon who is certified by three surgical boards and serves as a Clinical Professor at The George Washington University School of Medicine, brings the Company more than twenty years of experience in the cosmetic surgery, cosmetic skin treatment, and brand-name and private-label skincare sectors through his long-established practice at both his Washington, DC Center for Cosmetic Surgery, and his surgical practice in Dubai, as well as through his proven leadership in the industry.  For example, Dr. Hopping was elected by his peers as President of the American Academy of Cosmetic Surgery ("AACS") and of the American Academy of Cosmetic Surgery Foundation, among many other recognitions and achievements.

Robert Kane, President of X-Change Corp. stated, "It is a privilege and honor to announce the appointment of Dr. Steven B. Hopping as Senior Medical Advisor to the Company.   Dr. Hopping's sterling reputation, proven expertise in skin and skincare-based medicine, and national and international prominence in strategically important industry sectors will serve well the X-Change Corp. and its Phytiva brand product line as the Company continues its rapid growth into cosmeceutical and nutraceutical solutions and markets around the world."

About Steven B. Hopping, M.D., F.A.C.S.

Dr. Steven B. Hopping received his specialty training at Harvard University and has been practicing cosmetic surgery for over 20 years, assisting patients across the United States and around the world.  Dr. Hopping is Board Certified by three separate surgical boards: The American Board of Cosmetic Surgery, The American Board of Facial Plastic and Reconstructive Surgery, and The American Board of Otolaryngology, Head and Neck Surgery. He is also a Diplomate of the American Board of Hair Restoration. Dr. Hopping is the Medical Director of The Center for Cosmetic Surgery and of the Washington Hair Institute in Washington, DC .  He also has an active practice in Dubai.  Dr. Hopping is a Clinical Professor of Surgery at George Washington University and is regarded by his peers as a highly talented and innovative cosmetic surgeon. He lectures at numerous national and international conferences each year and is recognized around the world as both a leader and innovator in the cosmetic sector.   Dr. Hopping has written numerous articles and been published in medical journals related to advances in cosmetic surgery, and is frequently sought out by the media as an authority in his field.  Locally, Dr. Hopping is known for his philanthropy in supporting the arts, fighting poverty, and extending cosmetic surgery opportunities to the less fortunate.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.41%
FB $118.07 -0.42%
GOOG $696.92 -0.18%
TSLA $234.91 -2.80%
YHOO $36.12 -1.10%


Chart of I:DJI
DOW 17,708.51 -182.65 -1.02%
S&P 500 2,060.14 -21.29 -1.02%
NASDAQ 4,765.0240 -52.57 -1.09%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs